{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:03Z","timestamp":1793978823688,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009391","name":"Kafkas University","doi-asserted-by":"publisher","award":["2025-FM-34"],"award-info":[{"award-number":["2025-FM-34"]}],"id":[{"id":"10.13039\/501100009391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119270","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:18:02Z","timestamp":1787552282000},"page":"119270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-8802","authenticated-orcid":false,"given":"Feyzi Sinan","family":"Tokal\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyma","family":"Ate\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Tokal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-035X","authenticated-orcid":false,"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmech.2026.119270_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cancers17071102","article-title":"Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119270_bib3","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.ejmech.2026.119270_bib4","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/cancers14174280","article-title":"Challenges for triple negative breast cancer treatment: defeating heterogeneity and cancer stemness","volume":"14","author":"Mahmoud","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119270_bib5","article-title":"Microtubule organization is essential for maintaining cellular morphology and function","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2026.119270_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2014.00153","article-title":"Microtubules and their role in cellular stress in cancer","volume":"4","author":"Parker","year":"2014","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119270_bib7","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/molecules30163314","article-title":"Recent advances in microtubule targeting agents for cancer therapy","volume":"30","author":"Assun\u00e7\u00e3o","year":"2024","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119270_bib8","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2174\/1871526522666220105114437","article-title":"Recent advances in combretastatin A-4 inspired inhibitors of tubulin polymerization: an update","volume":"29","author":"Baytas","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1040333","article-title":"Advances in antitumor research of CA-4 analogs carrying quinoline scaffold","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2018.04.011","article-title":"Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119270_bib11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/molecules25112560","article-title":"Combretastatins: an overview of structure, probable mechanisms of action and potential applications","volume":"25","author":"Karatoprak","year":"2020","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119270_bib12","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2174\/1385272825666210526151222","article-title":"Photopharmacology of azo-combretastatin-A4: utilizing tubulin polymerization inhibitors and green chemistry as the key steps","volume":"25","author":"Rastogi","year":"2021","journal-title":"Curr. Org. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119270_bib13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/molecules28041717","article-title":"Development of combretastatin A-4 analogues as potential anticancer agents with improved aqueous solubility","volume":"28","author":"Chen","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/s41598-022-05958-6","article-title":"Synthesis and characterization of novel combretastatin analogues of 1,1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies","volume":"12","author":"Egharevba","year":"2022","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119270_bib15","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1021\/acs.jmedchem.6b01268","article-title":"Potent antitumor activities and structure basis of the chiral \u03b2-Lactam bridged analogue of combretastatin A-4 binding to tubulin","volume":"59","author":"Zhou","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119270_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/jm049622b","article-title":"Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines","volume":"48","author":"Simoni","year":"2005","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119270_bib17","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/jm100345r","article-title":"4-(3-Halo\/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model","volume":"53","author":"Schobert","year":"2010","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119270_bib18","article-title":"The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: a review","volume":"355","author":"Kajal","year":"2022","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119270_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103569","article-title":"Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents","volume":"96","author":"El-Kashef","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108869","article-title":"Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations","volume":"164","author":"Turgut","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119270_bib21","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1055\/a-2541-1072","article-title":"Synthesis, characterization and in vitro and in silico biological evaluation of new Mannich-based rhodanine and thiazolidine-2,4-dione derivatives as potential anti-lung-cancer agents","volume":"36","author":"Ate\u015fo\u011flu","year":"2025","journal-title":"Synlett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1752-153X-7-179","article-title":"Synthesis and biological evaluation of combretastatin A-4 derivatives containing a 3'-O-substituted carbonic ether moiety as potential antitumor agents","volume":"7","author":"Ma","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2026.119270_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2014.05.006","article-title":"Design, synthesis and glucose uptake activity of some novel glitazones","volume":"56","author":"Kar","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118264","article-title":"Development of phenolic Mannich bases as \u03b1-glucosidase and aldose reductase inhibitors: in vitro and in silico approaches for managing diabetes mellitus and its complications","volume":"128","author":"Tokal\u0131","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.145703","article-title":"Design and synthesis of polymethoxy rhodanines as selective small-molecule candidates for breast cancers","volume":"1361","author":"Tokal\u0131","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119270_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/acs.inorgchem.1c03154","article-title":"Inhibition of microtubule dynamics in cancer cells by indole-modified latonduine derivatives and their metal complexes","volume":"61","author":"Wittmann","year":"2022","journal-title":"Inorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119270_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12272-026-01609-w","article-title":"Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations","volume":"49","author":"Lee","year":"2026","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2026.119270_bib28","doi-asserted-by":"crossref","first-page":"30052","DOI":"10.1039\/D6RA03557D","article-title":"Design, synthesis, and mechanistic evaluation of novel pyrazole\/thiazole chalcone hybrids as dual tubulin polymerization and COX-2 inhibitors with potent antiproliferative activity","volume":"16","author":"Saleem","year":"2026","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4155\/fmc-2022-0212","article-title":"An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors","volume":"15","author":"Weng","year":"2023","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119270_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41580-023-00593-z","article-title":"Principles and dynamics of spindle assembly checkpoint signalling","volume":"24","author":"McAinsh","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119270_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109778","article-title":"Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids","volume":"175","author":"Tokal\u0131","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116458","article-title":"Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation","volume":"272","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib33","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1038\/s41598-018-22382-x","article-title":"High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design","volume":"8","author":"Bueno","year":"2018","journal-title":"Sci. Rep."},{"issue":"50","key":"10.1016\/j.ejmech.2026.119270_bib34","doi-asserted-by":"crossref","DOI":"10.1039\/D3RA06790D","article-title":"Synthesis and evaluation of tirbanibulin derivatives: a detailed exploration of the structure\u2013activity relationship for anticancer activity","volume":"13","author":"Park","year":"2023","journal-title":"RSC Adv."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119270_bib35","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.3390\/ijms26189212","article-title":"Synthesis of novel tricyclic N-Acylhydrazones as tubulin polymerization inhibitors","volume":"26","author":"Corona","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119270_bib36","doi-asserted-by":"crossref","first-page":"17360","DOI":"10.1039\/D5RA09801G","article-title":"Sulfonamide derivatives as tubulin polymerization inhibitors: advances in structural mechanisms, structure\u2013activity relationships, and therapeutic potential in cancer treatment","volume":"16","author":"Gupta","year":"2026","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119270_bib37","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119270_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119270_bib39","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/molecules27051587","article-title":"Indole-based tubulin inhibitors: binding modes and SARs investigations","volume":"27","author":"Tang","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119270_bib40","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.3390\/ijms23074001","article-title":"A review of the recent developments of molecular hybrids targeting tubulin polymerization","volume":"23","author":"Ebenezer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"61","key":"10.1016\/j.ejmech.2026.119270_bib41","doi-asserted-by":"crossref","first-page":"38479","DOI":"10.1039\/C7RA04314G","article-title":"Identification of potential tubulin polymerization inhibitors by 3D-QSAR, molecular docking and molecular dynamics","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119270_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110081","article-title":"2,3-Dihydroquinazolin-4(1H)-one derivatives as potent aldose reductase inhibitors: a combined experimental and computational study","volume":"180","author":"Tokal\u0131","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejmech.2017.06.035","article-title":"Conventional and microwave-assisted synthesis of new 1H-benzimidazole-thiazolidinedione derivatives: a potential anticancer scaffold","volume":"138","author":"Sharma","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119270_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/17568919.2026.2620368","article-title":"New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors","volume":"18","author":"Tokal\u0131","year":"2026","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125006","article-title":"New tetrahydro-isoquinoline derivatives as cholinesterase and \u03b1-glycosidase inhibitors: synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studies","volume":"404","author":"Mamedov","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejmech.2026.119270_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109419","article-title":"Harnessing nature's building blocks: potent and safe urease inhibition by simple amino acids","volume":"169","author":"Ba\u011f","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138998","article-title":"Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: an in vitro-in silico study","volume":"1315","author":"Petrova","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119270_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117915","article-title":"Synthesis, characterization, in vitro and in silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-\u03b22 expression in colorectal carcinoma","volume":"296","author":"Ay","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119270_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108486","article-title":"Synthesis and evaluation of aldose reductase inhibition of new thiazolidine-quinazoline hybrids through in vitro and in silico approaches","volume":"118","author":"\u015eenol","year":"2025","journal-title":"Comput. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119270_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70048","article-title":"2-Propyl-3-Aminoquinazoline-4(3H)-one derivatives as potential androgen receptor inhibitors: synthesis and cytotoxicity against PC3 cell line via in vitro and in silico studies","volume":"358","author":"\u015eenol","year":"2025","journal-title":"Arch. Pharmazie"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:58:49Z","timestamp":1793977129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S0223523426007154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119270","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119270"}}